Aurobindo Pharma’s subsidiary, TheraNym Biologics Pvt Ltd, on Friday, May 31, announced setting up a biological manufacturing plant in Telangana. The company has signed a master service agreement with Merck Sharpe & Dohme Singapore (MSD) for the same.
As part of this collaboration, TheraNym will invest an estimated INR 1,000 Crore in establishing a biologics manufacturing facility in Telangana. This agreement will enable TheraNym to manufacture biological products for both domestic as well as international markets.
Also Read: Hindustan Coca-Cola Beverages Manufacturing Plant, Khed, Maharashtra
The proposed facility will feature large-scale bioreactors for mammalian cell culture products and a vial-filling isolator line capable of producing up to 25-30 million vials per year. TheraNym’s commitment to building this state-of-the-art facility underscores its dedication to advancing biopharmaceutical production and meeting global healthcare needs.
Biltrax Construction Data is tracking 30,000+ projects on their technology platform for their clients.
Get exclusive access to upcoming projects in India with actionable insights. Furthermore, gain a competitive advantage for your products in the Indian Construction Market.
Visit www.biltrax.com or email us at contact@biltrax.com to become a subscriber and generate leads.
Disclaimer: The information herein is based upon information obtained in good faith from sources believed to be reliable. All such information as well as opinions can be subject to change. Furthermore, The image featured in this article is for representation purposes only. It does not in any way represent the project. If you wish to remove or edit the article, please email editor@biltrax.com.
0Discover more from Biltrax Media, A Biltrax Group venture
Subscribe to get the latest posts sent to your email.
